The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida
- PMID: 12044132
- DOI: 10.7326/0003-4819-136-11-200206040-00013
The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida
Abstract
Recent years have witnessed a rapidly growing crisis in antimicrobial resistance, especially among microorganisms that cause nosocomial infection. To better understand common risk factors among multiresistant organisms, this review explores risk factors for nosocomial infection with methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococcus, Clostridium difficile, extended-spectrum beta-lactamase-producing gram-negative bacilli, and Candida. This review comprises data from 74 published studies; 53 (71%) were retrospective studies and addressed few risk factors or did not quantify risk. The analysis shows impressive commonality of risk factors across these diverse multiresistant organisms: advanced age; underlying diseases and severity of illness; inter-institutional transfer of the patient, especially from a nursing home; prolonged hospitalization; gastrointestinal surgery or transplantation; exposure to invasive devices of all types, especially central venous catheters; and exposure to antimicrobial drugs, especially cephalosporins. More restricted use of antibiotics, especially cephalosporins, and strategies to prevent medical device-related infection and cross-infection in the hospital would yield benefit with all types of resistant organisms. Preemptive isolation of all patients with risk factors for infection by resistant organisms would very likely reduce secondary spread within the hospital. Conversely, programs that focus on only one organism or one antimicrobial drug are unlikely to succeed. Prospective studies of sufficient size that address all potential risk factors, especially individual anti-infective agents, and that use matched controls who are shown by surveillance cultures to be free of colonization by resistant organisms would enhance understanding of the epidemiology of antimicrobial resistance in institutions and guide efforts to develop more effective strategies for prevention.
Similar articles
-
Vancomycin-resistant Enterococcus co-colonization rates with methicillin-resistant Staphylococcus aureus and Clostridium difficile in critically ill veterans.Am J Infect Control. 2016 Sep 1;44(9):1047-9. doi: 10.1016/j.ajic.2016.02.005. Epub 2016 Apr 7. Am J Infect Control. 2016. PMID: 27067517
-
Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis.Lancet Infect Dis. 2017 Sep;17(9):990-1001. doi: 10.1016/S1473-3099(17)30325-0. Epub 2017 Jun 16. Lancet Infect Dis. 2017. PMID: 28629876 Review.
-
Hospital-acquired infections: diseases with increasingly limited therapies.Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2420-7. doi: 10.1073/pnas.91.7.2420. Proc Natl Acad Sci U S A. 1994. PMID: 8146133 Free PMC article. Review.
-
Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.J Microbiol Immunol Infect. 2006 Apr;39(2):135-43. J Microbiol Immunol Infect. 2006. PMID: 16604246
-
Clostridium difficile infection and concurrent vancomycin-resistant Enterococcus stool colonization in a health care worker: case report and review of the literature.Am J Infect Control. 2003 Feb;31(1):54-6. doi: 10.1067/mic.2003.48. Am J Infect Control. 2003. PMID: 12548259 Review.
Cited by
-
Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system.Int J Clin Pharm. 2022 Dec;44(6):1351-1360. doi: 10.1007/s11096-022-01472-x. Epub 2022 Sep 30. Int J Clin Pharm. 2022. PMID: 36178607
-
Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission.Emerg Infect Dis. 2007 Aug;13(8):1144-9. doi: 10.3201/eid1308.070071. Emerg Infect Dis. 2007. PMID: 17953083 Free PMC article.
-
Implementing the MRSA recommendations made by the Commission for Hospital Hygiene and Infection Prevention (KRINKO) of 1999 - current considerations by the DGKH Management Board.GMS Krankenhhyg Interdiszip. 2009 Apr 9;4(1):Doc02. doi: 10.3205/dgkh000127. GMS Krankenhhyg Interdiszip. 2009. PMID: 20204102 Free PMC article.
-
Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections.Antimicrob Agents Chemother. 2005 Aug;49(8):3217-21. doi: 10.1128/AAC.49.8.3217-3221.2005. Antimicrob Agents Chemother. 2005. PMID: 16048928 Free PMC article. Clinical Trial.
-
Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections.Clin Microbiol Infect. 2016 Jun;22(6):513-9. doi: 10.1016/j.cmi.2016.01.023. Epub 2016 Feb 3. Clin Microbiol Infect. 2016. PMID: 26850824 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical